Infectious diseases Infectious diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients presenting with suspected respiratory infection who have new consented specimens or residual/stored specimens such as postnasal, nasopharyngeal, pharyngeal swabs, or sputum.
Exclusion criteria
Exclusion criteria: When consent is withdrawn When a request to refuse secondary use is made for stored specimens originating from other studies When no residual specimens remain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative performance evaluation of GENECUBE versus existing methods (e.g., LAMP) for M. pneumoniae detection in nasopharyngeal swabs. | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection of M. pneumoniae variants and drug susceptibility; evaluation of B. pertussis, C. pneumoniae, C. psittaci, Legionella, Rickettsia, Coxiella; pretreatment, composition, device settings; sensitivity, reproducibility, stability; cross-reactivity; magLEAD optimization; simultaneous detection of respiratory pathogens and resistance genes. | — |
Contacts
University of Tsukuba Hospital